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The three-dimensional structure of a chemically synthesized peptide that we have called ‘interme-
diate’ defensin-like peptide (Int-DLP), from the platypus genome, was determined by nuclear mag-
netic resonance (NMR) spectroscopy; and its antimicrobial activity was investigated. The overall
structural fold of Int-DLP was similar to that of the DLPs and b-defensins, however the presence
of a third antiparallel b-strand makes its structure more similar to the b-defensins than the DLPs.
Int-DLP displayed potent antimicrobial activity against Staphylococcus aureus and Pseudomonas
aeruginosa. The four arginine residues at the N-terminus of Int-DLP did not affect the overall fold,
but were important for its antimicrobial potency.
Crown Copyright  2014 Published by Elsevier B.V. on behalf of Federation of European Biochemical
Society. All rights reserved.1. Introduction and they act as antibiotics [3]. Peptides that adopt the b-defensinBioactive polypeptides such as those found in venoms, milk
and other natural sources have attracted considerable attention
in recent years because of their potential applications in drug
discovery programs [1,2]. Such molecules can be used as tools
to investigate important physiological mechanisms at the cellular
and/or molecular levels. They can also be used directly as drugs,
or as starting points to design new therapeutic agents. These
polypeptides are often of comparatively low molecular weight
and cysteine rich, and each has a speciﬁc disulﬁde-linked molec-
ular framework that can be used as a scaffold to create new bio-
active compounds.
Defensins are good examples of such potentially useful poly-
peptides. These small antimicrobial proteins are found in many
organisms, including mammals, birds, invertebrates and plants,structural fold in particular are interesting, as they are found in a
diverse range of organisms possessing disparate biological activi-
ties [4]. In humans and other mammals, b-defensins are produced
in neutrophils and epithelial cells, playing an important role in the
innate immune response as antimicrobial agents and as chemo-
kines [5–9]. Polypeptides similar in fold to b-defensins have also
been reported in toxins of sea anemones [10], snakes [11,12] and
platypus [13,14] where they display numerous pharmacological
activities, such as ion-channel inhibition, myonecrosis, and
analgesia.
The b-defensin-fold structure generally consists of a short helix,
or turn, followed by a small twisted anti-parallel b-sheet of three
strands [4]. The six cysteine residues that are paired in a 1–5, 2–
4 and 3–6 order in the primary structure are important for deter-
mining and maintaining the compact core conﬁguration of the
molecule. The low sequence similarity with other members of
the same family suggests that this global fold is chemically and
therefore evolutionarily robust, and that the nature of the side-
chains effectively determines the functional speciﬁcity. The dis-
tinct compact fold shared by these polypeptides may therefore
be useful in the design of molecules with prescribed pharmacolog-
ical activity.
1822 A.M. Torres et al. / FEBS Letters 588 (2014) 1821–1826The defensins from various tissues of the platypus, Ornithorhyn-
chus anatinus, and defensin-like peptides (DLPs) from its venom
present an intriguing and potentially valuable case for research
study. This transpires because the platypus is a unique animal that
possesses both mammalian and reptilian characteristics, thus
bridging the evolutionary gap between lower and higher animal
species. The male monotremes, platypus and echidna, for example,
are the only known mammals to bear a venomous spur on each
hind limb. Platypus envenomation in human victims causes excru-
ciating pain, hyperalgesia, and oedema [15]. The venom contains
numerous novel biologically active peptides and proteins, amongst
which are natriuretic peptides called Ornithorhyncus venom C-type
natriuretic peptides or OvCNPs, and a family of four polypeptides
of 5 kDa called DLPs. Both the OvCNPs and DLPs are known to ex-
ist in two isomeric forms, with each pair having identical amino
acid sequences but with the second amino acid residue in the
D-form [16].
Various assay experiments on DLPs have so far failed to estab-
lish their role in the venom. DLPs are neither antimicrobial, myo-
toxic, nor do they appear to affect Na+-channel currents [14,17].
The antimicrobial defensins from the platypus are equally as
intriguing as the DLPs. Six b-defensins and four a-defensins have
so far been identiﬁed from platypus genome analysis [18]. The dis-
covery of the a-defensins in the genome suggests that this type of
defensin has evolved from b-defensins and that they emerged phy-
logenetically prior to the divergence of the three extant mamma-
lian lineages, 210 mya. Besides this phenomenon, a new 44
amino acid residue peptide designated DEFB-VL (venom-like b-
defensin) or intermediate-DLP (Int-DLP) was discovered in a gene
analysis of the platypus genome [18]. Int-DLP has an amino acid
sequence similar to both mammalian (including the platypus) b-
defensins and the DLPs (see Fig. 1). It was suggested that this poly-
peptide evolved from platypus defensins to ﬁnally form the DLPs of
the platypus venom, and hence we posit that it is ‘transitional’ be-
tween the two types of polypeptides. Thus, it was expected that
Int-DLP would display folding characteristics that are similar to
b-defensins and/or the platypus venom DLPs. Preliminary struc-
tural modeling showed that Int-DLP had a similar fold to the DLPs
and may have antimicrobial activity [18].
In the present work we investigated in greater details the ter-
tiary structure of Int-DLP in solution and its antimicrobial activity.
The results obtained add to a more general understanding of the
evolution of defensins and the possible role of DLPs in the platypus
and potentially higher mammals.
2. Methods
2.1. Sample preparation and synthesis
The 44-residue Int-DLP was synthesized on a 0.50 mmol scale
using HBTU activation of Boc-amino acids with in situ neutraliza-
tion chemistry, as described previously [19]. The 40-residue Int-
DLPa was purchased from GL Biochem Ltd. (Shanghai, China).Int-DLP       RRRRRRPPCEDVNGQCQPRGN-PC-LRLRGAC-PRGSRCCMPTVAAH 
PVPMRQIGTCFGRPVKCCRCGRNGGVCIPIRCβ-defensin-12 GPLS---- - ----SW
DLP-1  FVQHRPRDCESINGVCRHKDTVNCREIFLADCYNDGQKCC -----RK
10 20 30 40
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Fig. 1. Primary structures of DLP-1, Int-DLP, and b-defensin-12. The amino acid
residues were aligned using Kalign [35] to show maximum correspondence
between the structures. Shaded regions indicate identical residues. The disulﬁde
bonding pairs are shown below the numbered sequences with dashed lines.NMR samples were prepared by dissolving 1–2 mmol of peptide
samples in 0.350 mL of H2O/D2O (9:1, v/v) in a 5-mm magnetic
susceptibility matched Shigemi (Allison Park, PA, USA) NMR tube.
The pH values of the samples were 3.5.
2.2. Antimicrobial activity assay
Nutrient broth was prepared with 13 g of medium powder ob-
tained from Oxoid (Australia) in 1 L of deionised H2O. The ﬁnal pH
of the medium was 7.0. Nutrient gel was prepared with bacterio-
logical agar (1 g L1), bacteriological peptone (10 g L1), yeast ex-
tract (5 g L1), and sodium chloride (5 g L1). The bacteria used in
the antimicrobial activity assay were Staphylococcus aureus (ATCC
12600), Escherichia coli (ATCC 11775), and Pseudomonas aeruginosa
(ATCC 19582) which were obtained from the University of New
South Wales [20]. Among these, S. aureus is a Gram-positive bacte-
rium while E. coli and P. aeruginosa are Gram-negative bacteria. Li-
quid cultures of nutrient broth (20 mL) for each microorganism
were inoculated with a single colony from the stock agar plates
and grown overnight (18 h) with shaking at 150 rpm before dilu-
tion to 0.2 of OD595. Cultures were inoculated with the peptides
at the ﬁnal concentrations (lM) of 78, 39, 19.5, and 0, in 96-well
microtitre plates with shaking at 600 rpm. Initial readings were
made at the start of incubations, and the ﬁnal growth was read
at 24 h, using a 96-well plate reader (Multiskan EX, Thermo Elec-
tron). The screenings were carried out in duplicate. Growth inhibi-
tion values were estimated from the following expression:
Average of differences in net growth between the control and treated OD595
Average of net growth of the control OD595
100%2.3. NMR spectra and structural analysis
NMR spectra were recorded on Bruker Avance III 800, 600, and
500 spectrometers with 5-mm triple resonance inverse probes,
with operating temperatures of 15, 25, 30, and 35 C. The two-
dimensional homonuclear proton (2D) experiments that were per-
formed included double-quantum ﬁltered correlation spectroscopy
(DQF-COSY) [21,22]; total correlation spectroscopy (TOCSY) [23]
with spin-lock periods of 60 and 90 ms; and nuclear Overhauser
enhancement spectroscopy (NOESY) [24] with mixing times of
200 and 250 ms. Solvent-signal suppression was achieved by
applying either presaturation or WATERGATE [25] pulse se-
quences. H-D exchange experiments were carried-out by adding
D2O to freeze-dried NMR samples and acquiring a series of 1D
spectra for at least 1 h, followed by a 5 h TOCSY spectrum. All spec-
tra were processed using TOPSPIN software (Bruker) and were ana-
lysed using the standard protocol in the program SPARKY (T.D.
Goddard and D.G. Kneller, SPARKY 3, University of California, San
Francisco).
2.4. Structure calculations and analysis
Distance constraints for structure calculations were obtained
from cross-peak volumes in the NOESY spectra, recorded at
25 C. Additional distant constraints from H-bonding were ob-
tained from a hydrogen–deuterium exchange experiment after
analysis of medium resolution structures. Automatic structure cal-
culations were performed with the program CYANA [26]. The ‘best’
20 structures with the lowest target function values were selected
from the 1000 structures that were generated; these were consid-
ered to be representative of the structure of Int-DLP. The 3D struc-
tures were visualized and analyzed using the program MOLMOL
[27].
Table 1
Structural statistics of the 20 Int-DLP structures.
Quantity Value
Distance restraints
Intraresidue (i–j = 0) 104
Sequential (|i–j| = 1) 138
Medium-range (|i–j| 6 5) 45
Long-range (|i–j| > 5) 130
Hydrogen bonds 24
Disulﬁde bonds 9
Total 450
Compliance with restraints
CYANA average target function value 0.66
Number of NOE violations > 0.30 Å 0
Atomic rms difference with the mean (Å)
Backbone atoms (10–40) 0.38 ± 0.10
Heavy atoms (10–40) 0.90 ± 0.12
Ramachandran plot statistics
Most favourable region (%) 58.8
Additionally allowed region (%) 38.6
Generously allowed region (%) 2.2
Disallowed region (%) 0.5
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3.1. NMR experiments
The primary structure of Int-DLP is peculiar among those of b-
defensins in that it incorporates six consecutive arginine residues
at the N-terminus. This unusual property was expected to compli-
cate the process of 1H NMR resonance (peak) assignment as it was
anticipated to cause extensive peak overlap of the arginine peaks.
Preliminary NMR experiments on Int-DLP indeed yielded spectra
with many overlapping broad peaks (see Supplemental Fig. 1).Fig. 2. The calculated Int-DLP structure. (A) Ensemble of 20 Int-DLP structures aligned by
secondary structures and disulﬁde connectivities. (C) Similar to (B) but rotated 90 abou
electrostatic potential. Surfaces with positive, negative and neutral electrostatic potential
(B). (E) Similar to (D) but rotated 90 about the assigned vertical axis. (F) Similar to (D) b
MOLMOL [27].Besides this, it was also seen that Int-DLP NMR peaks were broader
than those obtained earlier for DLP-1 and DLP-2 [13,14]. To address
these problems, we performed additional NMR experiments on an
Int-DLP analogue that we called Int-DLPa, a shorter peptide with
four arginine residues deleted from the N-terminus. It was antici-
pated that the deletion of these four consecutive residues would
simplify and improve the quality of the NMR spectra, but not alter
the overall fold of the polypeptide.
NMR spectra of Int-DLPa had peaks with linewidths that were
not signiﬁcantly narrower than those of Int-DLP; however the dele-
tion of the four arginine residues to make the Int-DLP analogue
simpliﬁed resonance assignment by lessening the peak overlap in
the pertinent regions of the spectra. Also, there were no signiﬁcant
changes in the chemical shifts of the remaining peaks in the Int-
DLPa spectra, suggesting that Int-DLPa and Int-DLP had very simi-
lar overall structural folds.
By comparing the NMR spectra of Int-DLP and Int-DLPa, we able
to assign most the resonances of the two polypeptides. As both sets
of NMR spectra were very similar, structure calculations were per-
formed only on the full-length Int-DLP. The summaries of the
structural data from the calculated Int-DLP structures are given
in Table 1.
3.2. Int-DLP structures
The 20 structures of Int-DLP of the ensemble are shown in
Fig. 2A. Despite the relatively broad 1H NMR peaks, the resolution
of the obtained structure was good, showing a root mean square
deviation (RMSD) from the mean structure of 0.38 Å, when back-
bone atoms of residues 10–40 were superimposed. The N- and C-
termini of Int-DLP were also seen to be disordered in a manner
similar to the DLPs [13,14,28].superimposing the backbone atoms of residues 10–40. (B) Ribbon diagram showing
t the assigned vertical axis. (D–F), Molecular surface of Int-DLP highlighted to show
s are drawn in blue, red and white, respectively. (D) Molecular orientation similar to
ut rotated 180 about the assigned vertical axis. The ﬁgures were generated using
β-defensin-12DLP-1 Int-DLP
Fig. 3. Comparison of three-dimensional structural folds of DLP-1, Int-DLP and b-
defensin-12. The ﬁgures were generated using MOLMOL [27].
1824 A.M. Torres et al. / FEBS Letters 588 (2014) 1821–1826As shown in Fig. 2B and C, Int-DLP has a compact tertiary fold
containing a helix and a b-sheet, laced together by three disulﬁde
bonds. This overall fold was analysed using PDBefold structure
search algorithm [29] and was found to be very similar with that
of b-defensins and the DLPs, as illustrated in Fig. 3. The disulﬁde
connectivities of 1–5, 2–4 and 3–6 (revealed by NMR spectroscopy)
are identical with that of the DLPs. The presence and locations of
the short sections of secondary structures in Int-DLP and the DLPs
were also very similar. The structures of DLP-1, -2 and -4 incorpo-
rate anti-parallel b-sheets from residues 15–18 and 37–40, and a
helix-like structure from residues 10–12 [13,14,28]. In comparison,
the Int-DLP structure contained a deﬁnite anti-parallel b-sheet that
encompassed residues 15–17 and 35–38 and it also contained an
a-helix from residues 8–11.
3.3. Presence of third antiparallel b-strand as in b-defensin
Unlike the DLPs from the platypus, which possess only two
b-strands, many anti-microbial b-defensins from mammalian
sources, such as hBD-1, hBD-2 and b-defensin 12, incorporate three
b-strands [4,9,30,31]. Int-DLP displayed a third b-strand similar to
the b-defensins encompassing residues 24–27 with a b-bulge at
residues 26–27 (see Fig. 3). The chemical shift deviations from ran-
dom coil values, as shown in Supplemental Fig. 2, also support the
presence of this b-strand but suggest that that this strand could be
longer, perhaps spanning residues 21–26.0
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Fig. 4. Antimicrobial activities of Int-DLP and Int-DLPa. The antimicrobial activities of
aeruginosa (ATCC 19582) are expressed as a percentage of growth inhibition. Data repres
horizontal bars.It is clear that the third b-strand in Int-DLP makes its overall
structure more similar to b-defensins than to DLPs. Although the
cysteine spacing in Int-DLP is more similar to other b-defensins
in the platypus, the amino acid sequence of Int-DLP is more similar
to DLPs than to b-defensins [18]. The N-terminus that incorporates
four arginine residues was found to be disordered (and could be
ﬂexible) due to the dearth of medium and long-range NOESY
cross-peaks corresponding to this part of the molecule. These N-
terminal residues did not appear to have a signiﬁcant role in the
overall fold of Int-DLP as the chemical shifts of the 1H atoms of
Arg 5 and Arg 6 in Int-DLP and Int-DLPa were very similar.
3.4. Antimicrobial activity
The antimicrobial activity of Int-DLP and Int-DLPa were tested
against three bacterial species viz., S. aureus, E. coli, and P. aerugin-
osa. Fig. 4 shows the antimicrobial activity of the Int-DLP polypep-
tide with various concentrations, expressed as a percentage of
growth inhibition in the three different bacterial cultures.
Although growth inhibition was observed for all three species,
there were signiﬁcant differences in the potency of the peptides.
Both peptides showed consistent activity against S. aureus and
the least activity against E. coli. For E. coli, the very slight activity
(at less than 5% growth inhibition at 39 lM polypeptide) observed
for both polypeptides suggests insigniﬁcant or no activity against
this microorganism. For S. aureus, a consistent activity of 10%
growth inhibition occurred with the two peptides at concentra-
tions of 20–78 lM. Int-DLPa showed uniform activity of 8–9%
at concentrations of 20–78 lM, while Int-DLP showed slightly
higher activity of 12% at 39 and 78 lM; but its activity decreased
by 30% when its concentration was decreased to 20 lM.
With P. aeruginosa, there were signiﬁcant differences in the
antimicrobial activities of the two polypeptides. With 78 lM Int-
DLP the growth inhibition was 18%, which was 3 times higher
than the 7% obtained with Int-DLPa. Unlike that seen with S. aur-
eus, growth inhibitions in P. aeruginosa for the two polypeptides
decreased almost linearly with concentration.
As clearly shown by our results, Int-DLP and Int-DLPa had
antimicrobial properties, unlike the DLPs which had none
[13,14]. Int-DLP was seen to be more potent than Int-DLPa against0
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both of the peptides against E. coli (ATCC 11775), S. aureus (ATCC 12600), and P.
ent the average of two replicates with very small standard deviations shown by the
A.M. Torres et al. / FEBS Letters 588 (2014) 1821–1826 1825P. aeruginosa. It is surmised that the deletion of the four arginine
residues in Int-DLPa caused the observed decrease in activity and
that these arginine residues are important for Int-DLP anti-
microbial potency. This is consistent with the known activity of
stretches of arginine and lysine residues that mediate cell entry
of membrane-crossing peptides like penetratin [32].
The antimicrobial activity of Int-DLP is not surprising as it can
be readily explained by the obtained 1H NMR-based structure. As
shown in the surface diagrams in Fig. 2D–F, there is a clear separa-
tion between various types of amino acid in the Int-DLP molecule.
The membrane-active cationic arginine residues (blue surface) are
largely situated on one side of the molecule while clusters of
hydrophobic residues (white surface) are situated on the other
side. The amphipathic nature of Int-DLP is similar to that of defen-
sins, such as b-defensin-12. It is believed that this structural fea-
ture is responsible for defensins antimicrobial activities as it
facilitates interaction with targets such as bacterial membranes
[5].
An interesting feature of the Int-DLP structure is the cluster
of cationic residues. In human b-defensins, hBD-1, hBD-2, and
hBD-3, these membrane active basic residues are located at the
C-terminus [3] while in Int-DLP they are at the N-terminus. Note
that in antimicrobial studies of hBD-3 analogues [33] a linear
peptide fragment corresponding to the C-terminus gave en-
hanced activity against E. coli, a Gram-negative bacterium, while
the linear fragment corresponding to the N-terminus was active
against S. aureus, a Gram-positive bacterium. Since the position
of the basic residues in Int-DLP is reversed, in contrast to that
of human b-defensins, it might be expected that the N-terminus
of Int-DLP is important for ‘attacking’ Gram-negative bacteria.
While no signiﬁcant activity against E. coli was detected for
Int-DLP, it was evident that the four arginine residues at its N-
terminus were important for activity against P. aeruginosa, a
Gram-negative bacterium.
In addition to the previously mentioned structural feature, we
suggest that the proline residues in Int-DLP play a signiﬁcant part
in the overall fold and hence the antibacterial activity. As shown in
Fig. 1, b-defensin-12 and Int-DLP have four and ﬁve proline
residues, respectively, but DLP-1 has only one. The presence of
two consecutive proline residues near the N-terminus of Int-DLP
probably gives a speciﬁc orientation to the six cationic arginine
charged groups so that they interact with the cell membrane lead-
ing to enhanced antimicrobial activity. In the same manner, the
presence of other proline residues at the same, or nearly same,
position in the sequence of Int-DLP and b-defensin-12 makes their
structures more similar and hence a similar antimicrobial activity
or spectrum.
4. Concluding remarks
Overall, we determined the structural fold and antimicrobial
activity of another polypeptide from the platypus genome: Int-
DLP displays the robust structural fold of the b-defensin family of
polypeptides, incorporating a helix and a triple stranded b-sheet.
It also exhibited antibacterial activity although gene and amino
acid sequence analyses show that Int-DLP is more similar to DLPs,
which are devoid of antimicrobial activity, than to b-defensins. It is
possible that Int-DLP constitutes an evolutionary link between the
b-defensins and the DLPs. Further phylogenetic study similar to
that performed on fungal defensin-like peptides [34] will help
determine if this ‘intermediate’ molecule has indeed evolved from
b-defensins and is the precursor of the DLPs. It would also be inter-
esting to characterise the other unique defensins that have been
identiﬁed in the platypus genome [18] and to compare their struc-
tures and antimicrobial activities with those of other mammalian
defensins, and with Int-DLP. Such future studies may yieldeffective antimicrobials that can be used to treat newly emergent
drug-resistant bacteria that have been inadvertently selected by
overuse of conventional antibiotics.
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